Detailed Product Description The BPC-157 + TB-500 peptide blend combines two investigational agents with complementary regenerative actions
The neuroprotective mechanisms may involve modulation of inflammatory responses within the central nervous system, promotion of neuronal survival, and enhancement of axonal regeneration and synaptic plasticity
In vitro studies on human keratinocytes show a reduction in inflammatory cytokine production of over 50%
For research-use peptide products, public content should avoid athlete-use recommendations, training-specific protocols, competition positioning, or claims that peptides help athletes continue performing despite chronic soft tissue symptoms
The blend is convenient when a 1:1 ratio (5mg each) matches the research protocol and the goal is studying the combination effect
Health Canada continues to identify products marketed as For Research Use Only Not for Human Consumption. This type of labelling does not make these products legal or exempt from regulatory requirements